UNDA 270 (Seroyal USA)
Welcome to the PulseAid listing for the UNDA 270 drug offered from Seroyal USA. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Seroyal USA |
NON-PROPRIETARY NAME: | Equisetum arvense, Hypericum perforatum |
SUBSTANCE NAME: | HYPERICUM PERFORATUM; EQUISETUM ARVENSE TOP |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | TOPICAL |
DOSAGE FORM: | CREAM |
MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
START MARKETING DATE: | 2015-06-01 |
END MARKETING DATE: | 0000-00-00 |
UNDA 270 HUMAN OTC DRUG Details:
Item Description | UNDA 270 from Seroyal USA |
LABELER NAME: | Seroyal USA |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1; 1([hp_X]/40g; [hp_X]/40g) |
START MARKETING DATE: | 2015-06-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 62106-0097_5abbb3c6-660c-4176-e053-2991aa0aeff8 |
PRODUCT NDC: | 62106-0097 |
APPLICATION NUMBER: | |
Other HYPERICUM PERFORATUM; EQUISETUM ARVENSE TOP Pharmaceutical Manufacturers / Labelers: